The phosphatidylinositol-3-kinase (PI3K)/Akt serine/threonine kinase (AKT) pathway—a key signaling pathway controlling cell survival and metabolism—is frequently deregulated in cancer and has been the target of drug discovery14. The gene discussed is AKT1; the disease is cancer.